Compare Johnson & Johnson (JNJ) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Lufax Holding Ltd — how do they compare? Johnson & Johnson trades at $258.9 (market cap $626.09B), while Lufax Holding Ltd trades at $1.56 (market cap $2.41B). The key difference: Johnson & Johnson is far larger — about 259.8× Lufax Holding Ltd's market cap, and Johnson & Johnson pays a 2.06% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals.
| JNJ | LU | |
|---|---|---|
Market Cap | $626.09B | $2.41B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $4.40 |
52-Week Low | $172.78 | $1.23 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
